Optimal Blood Management in Elective Orthopaedic Surgery: The Transfusion "Op Maat" (TOMaat) Study.
Phase of Trial: Phase IV
Latest Information Update: 08 May 2012
At a glance
- Drugs Recombinant erythropoietin (Primary)
- Indications Perioperative haemorrhage
- Focus Therapeutic Use
- Acronyms TOMaat
- 08 May 2012 Planned patient number is 2250 according to Netherlands Trial Register.
- 08 May 2012 New source identified and integrated (Netherlands Trial Register; NTR303).
- 02 Nov 2009 New trial record